Community issues in gastroesophageal reflux disease: What we know and what we do not know

被引：6

作者：

Bjorkman, DJ ^{[1
]}

机构：

[1] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2001年 / 96卷 / 08期

关键词：

D O I：

10.1016/S0002-9270(01)02589-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S34 / S37

页数：4

共 35 条

[1]

ADELROTH E, 1986, AM REV RESPIR DIS, V134, P704

[2]

Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a Medicaid population of asthmatic patients [J].

Balkrishnan, R ;

Norwood, GJ ;

Anderson, A .

CLINICAL THERAPEUTICS, 1998, 20 (03) :567-580

[3]

Asthma: Better outcome at lower cost? The role of the expert in the care system [J].

Bartter, T ;

Pratter, MR .

CHEST, 1996, 110 (06) :1589-1596

[4]

OMEPRAZOLE OR RANITIDINE PLUS METOCLOPRAMIDE FOR PATIENTS WITH SEVERE EROSIVE ESOPHAGITIS - A COST-EFFECTIVENESS ANALYSIS [J].

BLOOM, BS ;

HILLMAN, AL ;

LAMONT, B ;

LISS, C ;

SCHWARTZ, JS ;

STEVER, GJ .

PHARMACOECONOMICS, 1995, 8 (04) :343-349

[5]

CARLSSON, PRESENTATION SLIDES

[6]

Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023

[7]

Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212

[8]

The epidemiology of gastroesophageal reflux disease: What we know and what we need to know [J].

Eisen, G .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (08) :S16-S18

[9]

Frank P, 1996, BRIT J GEN PRACT, V46, P295

[10]

QUALITY-OF-LIFE AND COST OF THERAPY IN REFLUX DISEASE [J].

GLISE, H .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 :38-42

← 1 2 3 4 →